Ignite Creation Date:
2025-12-24 @ 7:19 PM
Ignite Modification Date:
2025-12-25 @ 4:57 PM
Study NCT ID:
NCT01160003
Status:
COMPLETED
Last Update Posted:
2017-06-14
First Post:
2010-07-08
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Blinded, Dose Ascending Study to Assess the Pharmacokinetics, Safety and Tollerability of Repeat Inhaled Doses of Nebulised GW870086X in Healthy Adult Male Volunteers.
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-07-29
Start Date Type:
ACTUAL
Primary Completion Date:
2010-11-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-11-05
Completion Date Type:
ACTUAL
First Submit Date:
2010-07-08
First Submit QC Date:
None
Study First Post Date:
2010-07-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-13
Last Update Post Date:
2017-06-14
Last Update Post Date Type:
ACTUAL